ARCHIVES

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008